EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

E2F1 suppresses Epstein-Barr virus lytic reactivation through cellular and viral transcriptional networks

Joyanta Biswas, Sk Asif Ali, Samaresh Malik, Subhadeep Nag, Piyali Mukherjee, Abhik Saha iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Joyanta Biswas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Presidency University, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: E2F1 Transcription Factor, Herpesvirus 4, Human, Virus Activation, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Department of Biotechnology (DBT), Govt of India, DBT/Wellcome Trust India Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) establishes life-long persistence infection displaying a biphasic viral life cycle - latent phase and lytic replication. While latent EBV infection is linked to several B- and epithelial cell malignancies, periodic lytic-cycle reactivation is crucial for maintaining viral progeny and transmission. Targeting lytic reactivation offers a promising therapeutic avenue for EBV-associated cancers. Our genome-wide transcriptomic analysis reveals that E2F1 is transcriptionally activated during EBV latency but significantly suppressed during lytic reactivation. While ectopic E2F1 expression suppresses lytic replication, E2F1 depletion markedly accelerates this process. Mechanistically, we establish that E2F1 and the lytic transactivator BZLF1 form a negative transcriptional feedback loop, tightly controlling viral lytic replication. Furthermore, E2F1 positively regulates c-Myc expression and together they repress leaky BZLF1 expression during latency. Notably, c-Myc does not influence E2F1 expression, nor does BZLF1 modulate c-Myc transcription, underlining a distinct regulatory hierarchy. In sum, our findings reveal that EBV tightly controls the latent-to-lytic switch through precise regulation of E2F1 expression, positioning E2F1 as a pivotal regulator of both cellular and viral gene expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

E2F1 Transcription FactorHerpesvirus 4, HumanVirus ActivationEpstein-Barr Virus InfectionsGene Expression Regulation, ViralGene Regulatory NetworksHumansVirus LatencyTrans-ActivatorsVirus ReplicationProto-Oncogene Proteins c-myc

Substanzen

E2F1 Transcription FactorE2F1 protein, humanBZLF1 protein, Herpesvirus 4, HumanTrans-ActivatorsProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Institute of Health Sciences, Presidency University, Kolkata, West Bengal, India.

ORCID-Profile: Abhik Saha

Förderung

  • Wellcome Trust
  • Department of Biotechnology (DBT), Govt of India
  • DBT/Wellcome Trust India Alliance
  • Anusandhan National Research Foundation (ANRF), Govt. of India

Zitieren

APA

Biswas, J., Ali, S. A., Malik, S., Nag, S., Mukherjee, P., & Saha, A. (2025). E2F1 suppresses Epstein-Barr virus lytic reactivation through cellular and viral transcriptional networks. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013410

Vancouver

Biswas J, Ali SA, Malik S, Nag S, Mukherjee P, Saha A. E2F1 suppresses Epstein-Barr virus lytic reactivation through cellular and viral transcriptional networks. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013410

BibTeX
@article{Biswas2025,
  author = {Biswas, Joyanta and Ali, Sk Asif and Malik, Samaresh and Nag, Subhadeep and Mukherjee, Piyali and Saha, Abhik},
  title = {E2F1 suppresses Epstein-Barr virus lytic reactivation through cellular and viral transcriptional networks},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013410}
}
Kostenlos starten →